Injuries and osteoarthritis of the knee are common. Fortunately, there are many ways to prevent and treat knee pain.

The Food and Drug Administration has granted Fast Track designation to GNSC-001 for the treatment of osteoarthritis of the knee.

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

GNSC-001 is an investigational, adeno-associated virus gene therapy expressing an optimized form of IL-1Ra. The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

“The findings support the use of once-weekly subcutaneous semaglutide at a dose of 2.4 mg for weight management and treatment of pain in persons with obesity and moderate-to-severe pain due to knee ...

Sixty-nine-year-old Mary Anne Laporte was diagnosed with knee arthritis 15 years ago. For years, she kept the pain under control with steroid injections and physical therapy, but when she began ...

Long acting injection Fluticasone promising in knee osteoarthritis suggests a new study published in the The Lancet ...